Pilot Study of B Vitamin Therapy for Parkinson's Disease

This research study is looking at how B vitamins might help people with Parkinson's disease who are taking levodopa. We are studying if a daily combination of Folic Acid (1mg), Vitamin B6 (25mg), and Vitamin B12 (1,000ug) can lower high levels of homocysteine in your blood. High homocysteine levels are being investigated for their impact on thinking and memory (cognitive function). We are looking for 150 participants between 40 and 90 years old who have Parkinson's disease, are taking at least 300mg of levodopa daily, and have a certain score on a memory test (Montreal Cognitive Assessment or MOCA ≥15). The main goal is to see if this B vitamin therapy can correct high homocysteine and B vitamin deficiencies.

Study design
This is an open-label interventional study, meaning both you and the researchers will know what treatment you are receiving. It plans to enroll 150 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The study measures homocysteine and B vitamin levels at the beginning (baseline measurement).

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06772220

Pilot Study of Open Label Homocysteine Management Therapy in Levodopa-treated Parkinson's Disease

Recruiting
NAAges 40–90InterventionalTreatment
Oregon Health and Science University
~150 participants
Updated 2025-01-13 on ClinicalTrials.gov
What's tested:Folic Acid 1 MGVitamin B6 25 MGVitamin B12

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Hyperhomocysteinemia and B vitamin deficiency
Measured over baseline measurement
+2 more outcomes measured
Parkinson&Amp;#39;s Disease

NCT06772220

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Oregon Health & Science University (OHSU)

    Portland, Oregonstudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

  • Joseph Quinn, MD · PRINCIPAL_INVESTIGATOR · Oregon Health & Science University (OHSU)

Opens a ready-to-send draft in your own email app — review before sending.

  • Hyperhomocysteinemia and B vitamin deficiencybaseline measurement

    Plasma vitamin B12 in subjects with vs without hyperhomocysteinemia

  • Hyperhomocysteinemia and B vitamin deficiencybaseline measurement

    Plasma folic acid in subjects with vs without hyperhomocysteinemia

  • Hyperhomocysteinemia and B vitamin deficiencybaseline measurement

    Plasma pyridoxine in subjects with vs without hyperhomocysteinemia